← Back to Search

Behavioral Intervention

Immediate Start for Pediatric Cancer

Phase 1

Waitlist Available

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 0, ~week 2 (post-transplant), ~week 4 (hospital discharge), intervention or wait period week 4, intervention or wait period week 8.

Awards & highlights

Study Summary

This trial will investigate how a virtual reality game that combines mindfulness and exercise can help children with cancer during their recovery. The game will last for 8 weeks and can be used at home. Some participants

Who is the study for?

This trial is for children undergoing cancer rehabilitation. They must be able to participate in virtual reality gaming and mindfulness exercises over an 8-week program, starting either immediately or after a wait period.Check my eligibility

What is being tested?

The study tests if virtual reality games that focus on exercise and mindfulness can benefit kids recovering from cancer. It compares two groups: one starts the program right away, the other waits for 8 weeks before beginning.See study design

What are the potential side effects?

Since this involves virtual reality gaming, potential side effects may include dizziness, nausea, eye strain or headaches. However, these are typically mild and vary from person to person.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 0, ~week 2 (post-transplant), ~week 4 (hospital discharge), intervention or wait period week 4, intervention or wait period week 8.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 0, ~week 2 (post-transplant), ~week 4 (hospital discharge), intervention or wait period week 4, intervention or wait period week 8.

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0, ~week 2 (post-transplant), ~week 4 (hospital discharge), intervention or wait period week 4, intervention or wait period week 8. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Physical activity

Secondary outcome measures

Forced Expiratory Volume in the first second (FEV1)

Global Health

Minutes of gameplay

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Immediate StartExperimental Treatment1 Intervention

Program starts in the hospital and lasts for 8 weeks after hospital discharge.

Group II: Waitlist ControlActive Control1 Intervention

After 8 weeks after hospital discharge, these participants start the 8 week intervention.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,591 Previous Clinical Trials

2,281,649 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"As per the details available on clinicaltrials.gov, this research is not currently open for enrollment. The trial was initially posted on April 1st, 2024 and last updated on February 29th, 2024. Despite this study being closed to recruitment, there are a total of 51 other ongoing trials that are actively accepting participants at present."

Answered by AI

Has Immediate Start been authorized by the FDA for use?

"The safety rating for Immediate Start is a 1 as per our evaluation at Power, being classified under Phase 1 trial with minimal data backing its safety and effectiveness."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation

Byron Lai 2024. "Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06298357.

All > Pediatric Cancer